Exploring serum APRIL as a potential breakthrough biomarker for early detection of pancreatic cancer, the silent killer with devastating survival rates.
Exploring how mistletoe's bioactive compounds may inhibit p63 in pancreatic cancer treatment through computational analysis and clinical evidence.
Exploring the revolutionary applications of gold nanoparticles in pancreatic cancer treatment through photothermal therapy, targeted drug delivery, and radiation enhancement.
Exploring next-gen FK866 analogues targeting NAMPT for pancreatic cancer treatment with breakthrough molecular designs and combination strategies.